Statistics for Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma.
Total visits
| views | |
|---|---|
| Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma. | 81 |
Total visits per month
| views | |
|---|---|
| June 2024 | 13 |
| July 2024 | 1 |
| August 2024 | 1 |
| September 2024 | 4 |
| October 2024 | 2 |
| November 2024 | 2 |
| December 2024 | 0 |
File Visits
| views | |
|---|---|
| Efficacy_Agache_et_al_Allergy_2020.pdf | 20 |
Top country views
| views | |
|---|---|
| Spain | 33 |
| United States | 33 |
| Russia | 5 |
| China | 4 |
| United Kingdom | 3 |
| Australia | 2 |
| Ukraine | 1 |
Top city views
| views | |
|---|---|
| Madrid | 28 |
| San Mateo | 8 |
| Alicante | 2 |
| Valencia | 2 |
| Xiamen | 2 |
| Boydton | 1 |
| Brisbane | 1 |
| Gatchina | 1 |
| Moscow | 1 |
| Noginsk | 1 |
| Odintsovo | 1 |
| Qingdao | 1 |
| Seville | 1 |